Corazon (Corsee) D. Sanders, Director at BeiGene, Ltd. (BGNE), sold 1,056 shares at $182.65 ($193K) on 2023-06-23, disclosed to the SEC on 2023-06-27.
Scheduled sale ($193k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.74 | 100 | $18K | 9.4% |
| 2 | $182.65 | 478 | $87K | 45.3% |
| 3 | $182.65 | 478 | $87K | 45.3% |
| Total | $182.47 avg | 1,056 | $193K | 100% |
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |